Top compounds associated with response to ZNF285


Feature Type Standardized
Nominal ANOVA
mRNA avrainvillamide CTRPv2 pan-cancer AAC -0.044 0.3
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC -0.041 0.3
mRNA semagacestat CTRPv2 pan-cancer AAC -0.039 0.3
mRNA MS-275 CTRPv2 pan-cancer AAC -0.034 0.3
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.034 0.3
mRNA nakiterpiosin CTRPv2 pan-cancer AAC -0.035 0.3
mRNA tigecycline CTRPv2 pan-cancer AAC -0.05 0.3
mRNA BRD-K13999467 CTRPv2 pan-cancer AAC 0.037 0.3
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.3
mRNA SID 26681509 CTRPv2 pan-cancer AAC -0.039 0.3
Download CSV